Evidence map›Paper›PMID 35933399›Full record

ArticleNature communications2022

Spatiotemporal dynamics of macrophage heterogeneity and a potential function of Trem2

Seung-Hyun Jung, Byung-Hee Hwang, Sun Shin, Eun-Hye Park, Sin-Hee Park, Chan Woo Kim, Eunmin Kim, Eunho Choo, Ik Jun Choi, Filip K Swirski and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed, 2 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 2 syntheses or guidelines pooled it, 178 citations in OpenAlex.

  1. Pooled it
  2. Myocardial Immune Cells: The Basis of Cardiac Immunology.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Pooled it
  3. Review
  4. Decellularized cardiac ECM: A tissue-specific bioactive platform for drug release and cell delivery.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Macrophages and the Survival of Cardiomyocytes After Myocardial Infarction.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Seung-Hyun Jung *Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea. hyun@catholic.ac.kr.ORCID 0000-0003-1128-892X
Byung-Hee Hwang *Cardiovascular Research Institute for Intractable Disease, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Sun Shin *Departments of Microbiology, IRCGP, Cancer Evolution Research Center, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.ORCID 0000-0002-2146-4336
Eun-Hye ParkCardiovascular Research Institute for Intractable Disease, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Sin-Hee ParkCardiovascular Research Institute for Intractable Disease, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.ORCID 0000-0002-7452-9615
Chan Woo KimCardiovascular Research Institute for Intractable Disease, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.ORCID 0000-0001-8430-3903
Eunmin KimCardiovascular Research Institute for Intractable Disease, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Eunho ChooCardiovascular Research Institute for Intractable Disease, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Ik Jun ChoiDivision of Cardiology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Filip K SwirskiCardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-3163-9152
Kiyuk ChangCardiovascular Research Institute for Intractable Disease, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea. kiyuk@catholic.ac.kr.ORCID 0000-0003-3456-8705
Yeun-Jun ChungDepartment of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea. yejun@catholic.ac.kr.ORCID 0000-0002-6943-5948
Catholic University of Korea · KRSt. Mary's Hospital · USIcahn School of Medicine at Mount Sinai · USThe Catholic University of Korea Incheon St. Mary's Hospital · KR

Funding

Macrophages in homeostasis and cardiovascular diseaseR35HL135752 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SWIRSKI, FILIP K · 2017 to 2023
$5.4M
NHLBI NIH HHS R35 HL135752
6 · The paper itself

Abstract

Heart failure (HF) is a frequent consequence of myocardial infarction (MI). Identification of the precise, time-dependent composition of inflammatory cells may provide clues for the establishment of new biomarkers and therapeutic approaches targeting post-MI HF. Here, we investigate the spatiotemporal dynamics of MI-associated immune cells in a mouse model of MI using spatial transcriptomics and single-cell RNA-sequencing (scRNA-seq). We identify twelve major immune cell populations; their proportions dynamically change after MI. Macrophages are the most abundant population at all-time points (>60%), except for day 1 post-MI. Trajectory inference analysis shows upregulation of Trem2 expression in macrophages during the late phase post-MI. In vivo injection of soluble Trem2 leads to significant functional and structural improvements in infarcted hearts. Our data contribute to a better understanding of MI-driven immune responses and further investigation to determine the regulatory factors of the Trem2 signaling pathway will aid the development of novel therapeutic strategies for post-MI HF.

Indexed as

Heart FailureMyocardial InfarctionAnimalsBiomarkersDisease Models, AnimalLeukocyte CountMacrophagesMembrane GlycoproteinsMiceMice, Inbred C57BLMyocardiumReceptors, ImmunologicBiomarkersMembrane GlycoproteinsReceptors, ImmunologicTrem2 protein, mouse

Identifiers

PMID35933399
PMCPMC9357004
OpenAlexW4290034635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.